Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX10 plus nab-paclitaxel in advanced cervical cancer
CTR20192001Phase 2Terminated
- Sponsor
- Fosun Pharma
- Start
- Dec 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of serplulimab in Cervical Cancer (CC), sponsored by Fosun Pharma. Started Dec 2019; status: terminated.
02
Drugs
serplulimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on CTR20192001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192001.